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Abstract
Background: Persons of Pakistani origin living in Oslo have a much higher prevalence of vitamin
D deficiency and secondary hyperparathyroidism but similar bone mineral density compared with
ethnic Norwegians. Our objective was to investigate whether Pakistani immigrants living in Oslo
have an altered vitamin D metabolism by means of compensatory higher serum levels of 1,25-
dihydroxyvitamin D (s-1,25(OH)2D) compared with ethnic Norwegians; and whether serum levels
of ionized calcium (s-Ca2+) differ between Pakistanis and Norwegians.
Methods: In a cross-sectional, population-based study venous serum samples were drawn from
94 Pakistani men and 67 Pakistani women aged 30–60 years, and 290 Norwegian men and 270
Norwegian women aged 45–60 years; in total 721 subjects.
Results: Pakistanis had lower s-1,25(OH)2D compared with Norwegians (p < 0.001). Age- and
gender adjusted mean (95% CI) levels were 93 (86, 99) pmol/l in Pakistanis and 123 (120, 126) pmol/
l in Norwegians, p < 0.001. The difference persisted after controlling for body mass index. There
was a positive relation between serum 25-hydroxyvitamin D (s-25(OH)D) and s-1,25(OH)2D in
both groups. S-Ca2+ was higher in Pakistanis; age-adjusted mean (95% CI) levels were 1.28 (1.27,
1.28) mmol/l in Pakistanis and 1.26 (1.26, 1.26) mmol/l in Norwegians, p < 0.001. In both groups,
s-Ca2+ was inversely correlated to serum intact parathyroid hormone levels (s-iPTH). For any s-
iPTH, s-Ca2+ was higher in Pakistanis, also when controlling for age.
Conclusion: Community-dwelling Pakistanis in Oslo with low vitamin D status and secondary
hyperparathyroidism have lower s-1,25(OH)2D compared with ethnic Norwegians. However, the
Pakistanis have higher s-Ca2+. The cause of the higher s-Ca2+ in Pakistanis in spite of their higher
iPTH remains unclear.
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Vitamin D deficiency and secondary hyperparathyroidism
as defined by low serum 25-hydroxyvitamin D
(s-25(OH)D) and elevated serum parathyroid hormone
(s-iPTH) are common in immigrants from the Indian sub-
continent to Western countries [1,2], including Norway
[3]. Some researchers have found lower bone mineral
density (BMD) in immigrated Asian Indians and Pakista-
nis with a low vitamin D status compared with the Cauca-
sian host population [4,5]. In Oslo, however, Pakistani
immigrants (30–60 years) do not differ in bone mineral
density from ethnic Norwegians [6,7], despite lower
serum 25-hydroxyvitamin D levels (s-25(OH)D).
It has been speculated whether vitamin D deficient popu-
lations may have a modified vitamin D endocrine system
involving a compensatory increase in 1-α-hydroxylase
activity and thereby increased serum levels of the active
vitamin D hormone (1,25-dihydroxyvitamin D) in
response to their secondary hyperparathyroidism. This
would maintain their serum calcium levels and probably
protect against bone loss, by enhancing intestinal calcium
absorption and renal tubular calcium reabsorption.
Some small studies have reported higher BMD [8], and
higher [9] or similar serum 1,25-dihydroxyvitamin D
(s-1,25(OH)2D) [10] in African-Americans compared
with Caucasians, despite lower s-25(OH)D in African-
Americans. Serum ionized calcium (s-Ca2+) was similar in
African-Americans and Caucasians [9].
In a small US study (n = 18), vitamin D deficient Asian
Indian immigrants also had considerably higher
s-1,25(OH)2D when compared with Caucasians (n = 27)
[1], suggesting a compensatory mechanism in the vitamin
D endocrine system. S-Ca2+ was similar in the Asian Indi-
ans and the Caucasians.
In earlier studies from Norway, lower s-25(OH)D but
similar 1,25(OH)2D were observed in pregnant and pre-
menopausal Pakistani women in Oslo compared with
ethnic Norwegian women [7,11]. Pakistani and Norwe-
gian women had similar s-Ca2+ [7]. In contrast to these
older studies, the Oslo Health Study 2000–2001 is a
much larger, population-based study including samples
of the general population. It covers a wide age range, and
it also includes men. It has thus far been found in the Oslo
Health Study that although Pakistanis living in Oslo have
a very high prevalence of vitamin D deficiency and sec-
ondary hyperparathyroidism compared with ethnic Nor-
wegians [3], the two ethnic groups do not differ
substantially in bone turnover [12] or bone mineral den-
sity [6]. Based on this knowledge our research questions
were: Do persons with Pakistani background living in
Oslo have increased s-1,25(OH)2D when compared with
ethnic Norwegians, in order to compensate for low
s-25(OH)D? And, as a consequence of altered vitamin D
metabolism, does s-Ca2+ differ between Pakistanis and
Norwegians?
Methods
The data were collected as part of the Oslo Health Study
(HUBRO), a cross-sectional population-based multipur-
pose study conducted in 2000–2001, inviting all individ-
uals in the city of Oslo aged 30, 40, 45, 59, 60, 75 and 76
years. The overall attendance rate was 46% (n = 18,770),
varying from 36% in 30 years old to 55% in 59–60 years
old individuals. The material and methods, including
respondent rates, are described in detail elsewhere [13]. As
a substudy of HUBRO, bone mineral density and vitamin
D status were measured in the period May 2000 to January
2001. The participants recruited for the substudy were
random samples of individuals born in Norway (quoted
as Norwegians) aged 45, 60, and 75 years, as well as ran-
dom samples of individuals born in Pakistan (quoted as
Pakistanis) of all age groups in the Oslo Health Study. The
participants were invited in a random order throughout
the study period regardless of ethnic background. For the
current data analysis, we excluded those not having their
serum vitamin D metabolites measured, and the oldest
age group (75–76 years), as there were only three Pakista-
nis in this age group.
As previously described [12], of the 1281 Norwegians of
age 45–60 who were invited to the substudy, 674 (53%)
participated, and 584 (46%) had s-25(OH)D analyzed.
Of the 608 Pakistanis of age 30–60 who were invited to
the substudy, 237 (39%) participated, and 176 (29%) had
s-25(OH)D analyzed. An important reason for these dis-
crepancies was that the data collection for the substudy
was discontinued January 15th, 2001, and was thus not
performed on those who should have met before, but met
after January 15th. However, background characteristics
(smoking, BMI, and age) of those who participated in the
substudy did not differ from those who met after this date.
In addition, we excluded two Norwegian women and one
Pakistani woman due to primary hyperparathyroidism as
defined by s-iPTH ≥ 8.5 pmol/L and serum levels of ion-
ized calcium (s-Ca2+) > 1.35 mmol/L, and we excluded
one subject due to very low s-iPTH combined with high
s-Ca2+ (iPTH < 2.0 pmol/L and Ca2+ > 1.35 mmol/L),
which possibly indicate malignancy. In addition, two sub-
jects had unknown PTH status due to missing values, and
33 subjects had unknown s-1,25(OH)2D due to missing
values. Thus, the final sample for analysis consisted of a
total of 94 Pakistani men and 67 Pakistani women of age
30, 40, 45, and 59–60 years, and 290 Norwegian men and
270 Norwegian women of age 45 and 60 years; in total
721 subjects.Page 2 of 6
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All participants underwent a simple physical examination
and filled in self-administered questionnaires which
included information about various lifestyle factors [14].
A non-fasting blood sample was collected from each par-
ticipant on the day of attendance. Height and weight were
measured in light in-door clothing without shoes.
Blood sample analysis
The serum samples were first stored at -20°C for up to
eight weeks at the screening station, and then kept frozen
at -70°C until analyzed in the Hormone Laboratory, Aker
University Hospital.
S-25(OH)D and s-iPTH (intact PTH) were measured as
previously described [3]. S-1,25(OH)2D was measured by
competitive radioimmunoassay (DiaSorin, Stillwater,
MN, USA). Prior to the 1,25(OH)2D determination,
serum lipids and interfering vitamin D metabolites were
removed by chromatography on a C18OH column. Cross
reaction with 25(OH)D after chromatography is noted to
be 0.002%. The intra- and interassay coefficients of varia-
tion (CVs) for the s-1,25(OH)2D assay were 7 and 14%,
respectively. The limit of detection was 12 pmol/l.
S-Ca2+ was measured using an ion-specific electrode (Ciba
Corning Diagnostics, Essex, UK). The interassay CV was
2%. S-Ca2+ levels were adjusted to pH 7.40.
The analyses are not adjusted for time since last meal as
additional analyses showed that such adjustment did not
influence the levels of any of the metabolites.
Statistical analysis
Statistical tests were performed using the software SPSS
for Windows version 14.0. Ethnic differences in
s-1,25(OH)2D and s-Ca2+ were assessed by one-way anal-
ysis of variance (ANOVA) and linear regression. Associa-
tions between metabolites were assessed by linear
regression and correlation analysis. We corrected for body
mass index (BMI) in order to explore whether a difference
in s-1,25(OH)2D could be attributable to differences in
BMI. Additional data analyses were performed stratified
on ethnic background, gender and age.
Ethics
The study protocol was reviewed by the Regional Com-
mittee for Medical Research Ethics and approved by the
Norwegian Data Inspectorate. Written informed consent
was obtained from the participants.
Results
Serum 1,25-dihydroxyvitamin D levels in ethnic groups
Mean (95% CI) s-1,25(OH)2D for all participants was 117
(114, 119) pmol/l and ranged from 35 to 258 pmol/l.
S-1,25(OH)2D was considerably lower in Pakistanis than
in Norwegians (table 1). S-1,25(OH)2D did not differ
between men and women within each ethnic group, and
did not differ by age. The mean difference between Paki-
stani and Norwegian men and women combined was 30
(95% CI 23, 38) pmol/l, p < 0.001. When also controlling
for s-25(OH)D and s-iPTH, there was still an ethnic differ-
ence in s-1,25(OH)2D of 11 (95% CI 2, 20) pmol/l,
p = 0.014. There was a positive relation between
s-25(OH)D and s-1,25(OH)2D (In Norwegians: Beta =
0.4 pmol/l increase in s-1,25(OH)2D per 1 nmol/l
increase in s-25(OH)D; In Pakistanis: Beta = 0.7 pmol/l
increase in s-1,25(OH)2D per 1 nmol/l increase in
s-25(OH)D. P < 0.001 for both ethnic groups). Correla-
tion coefficients were r = 0.35 (p < 0.001) in Pakistanis
and r = 0.26 (p < 0.001) in Norwegians.
Pakistanis had higher BMI than Norwegians; unadjusted
mean 28.1 (95% CI 27.5, 28.7) kg/m2 in Pakistanis and
Table 1: Background characteristics and serum levels of 25-hydroxyvitamin D, intact parathyroid hormone, 1,25-dihydroxyvitamin D, 
and ionized calcium in Norwegians and Pakistanis
Men Women
Norwegians
n = 290
Pakistanis
n = 94
P (ethnicity),
ANOVA
Norwegians
n = 270
Pakistanis
n = 67
P (ethnicity),
ANOVA
Age (years) a 56 (55, 57) 43 (42, 45) < 0.001 55 (54, 56) 40 (38, 42) < 0.001
BMI, mean (SD) kg/m2 26.5 (3.4) 27.2 (3.8) 0.10 25.0 (4.1) 29.4 (4.9) < 0.001
s-25(OH)D (nmol/l) a 74.4 (71.7, 77.1) 30.0 (24.8, 35.3) < 0.001 76.2 (73.3, 79.1) 26.1 (19.4, 32.9) < 0.001
Range 27–207 6–68 19–168 6–70
s-iPTH (pmol/l) a 5.2 (4.9, 5.4) 6.0 (5.4, 6.5) 0.013 5.0 (4.7, 5.4) 6.9 (6.2, 7.7) < 0.001
Range 1.3–15.5 1.4–13.5 1.2–15.5 2.4–18.0
s-1,25(OH)2D (pmol/l) a 124 (120, 129) 94 (86, 102) < 0.001 122 (118, 127) 91 (81, 101) < 0.001
Range 60–251 43–214 35–225 58–258
s-Ca2+ (mmol/l)a 1.26 (1.26, 1.27) 1.28 (1.27, 1.28) 0.031 1.26 (1.25, 1.26) 1.28 (1.27, 1.29) < 0.001
Range 1.15–1.36 1.19–1.45 1.15–1.39 1.18–1.36
a Means and 95% confidence intervals, with age adjustment done separately within the genders.Page 3 of 6
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(p < 0.001). The ethnic difference in s-1,25(OH)2D per-
sisted after adjustment for BMI, although the adjusted eth-
nic difference in women was now 3 pmol/l smaller. In a
linear regression model, BMI was significantly inversely
associated with s-1,25(OH)2D in Norwegians (decrease of
-0.8 pmol/l per 1 kg/m2 increase in BMI, p = 0.036) but
not in Pakistanis. The interaction term for ethnic back-
ground and BMI on s-1,25(OH)2D was, however, not sta-
tistically significant.
Serum ionized calcium levels in ethnic groups
S-Ca2+ was higher in Pakistanis than in Norwegians (table
1) and the values were similar in men and women. S-Ca2+
did not vary by age except for a positive relation with age
in Norwegian women. For all age groups, estimates of
s-Ca2+ were higher in Pakistanis.
S-Ca2+ was not correlated to s-25(OH)D or
s-1,25(OH)2D. However, there was a clear inverse correla-
tion between s-Ca2+ and s-iPTH in both genders in both
ethnic groups (overall age-adjusted correlation r = -0.14,
p < 0.001), and it was stronger in Pakistanis. Pakistani
women, who had the highest prevalence of secondary
hyperparathyroidism, had an age-adjusted correlation of r
= -0.37 (p = 0.002) between s-Ca2+ and s-iPTH. In the nor-
mal range, at any s-iPTH level, Pakistanis had higher
s-Ca2+ (figure 1). For s-iPTH above 9 pmol/l, the pattern
was unclear due to few observations.
In a multiple linear regression model including ethnic
background, age, gender, s-25(OH)D, s-1,25(OH)2D, and
s-iPTH, the only significant predictors of s-Ca2+ were eth-
nic background (mean difference of 0.02 (95% CI 0.01,
0.03) mmol/l for Pakistanis vs. Norwegians, p < 0.001)
and s-iPTH (mean decrease of 0.03 (95% CI 0.02, 0.04)
mmol/l per 10 pmol/l increase in iPTH, p < 0.001). If we
excluded s-iPTH from the model, the vitamin D metabo-
lites did still not predict s-Ca2+ levels. S-iPTH seemed to
predict s-Ca2+ more strongly in Pakistanis, as Pakistanis
had a mean decrease of 0.04 (95% CI 0.02, 0.06) mmol/l
per 10 pmol/l increase in iPTH, p < 0.001, whereas Nor-
wegians had a mean decrease of 0.02 (95% CI 0.01, 0.04)
mmol/l per 10 pmol/l increase in s-iPTH, p = 0.007. How-
ever, the interaction term for ethnic background and
s-iPTH on s-Ca2+ was not statistically significant
(p = 0.068, adjusted for age and gender).
In a subsample, pH in venous serum samples was 7.54
(95% CI 7.53, 7.54) in Norwegians (n = 429) and 7.51
(95% CI 7.51, 7.52) in Pakistanis (n = 124), p < 0.001.
Discussion
We found that Pakistanis living in Oslo had low s-
1,25(OH)2D accompanying their low s-25(OH)D, which
may imply a substrate-limited production of
1,25(OH)2D. Thus, Pakistanis, who have a 4–5-fold
higher prevalence of vitamin D deficiency and secondary
hyperparathyroidism than ethnic Norwegians, do not
seem to compensate for their vitamin D deficiency by
increasing their production of 1,25(OH)2D. Interestingly,
we found higher s-Ca2+ in Pakistanis compared with Nor-
wegians. A limitation of the study was non-fasting blood
samples, which could influence s-iPTH and s-Ca2+ levels.
However, adjustment for time since last meal did not alter
the observed levels of these metabolites.
It has not been established how the endocrine system
handles subclinical vitamin D deficiency, and to which
degree this may vary according to ethnic background, age,
or body composition. Some studies have observed a com-
pensatory increased production of 1,25(OH)2D following
reduced s-25(OH)D. Thus Vieth et al. [15] observed an
inverse relationship between s-25(OH)D and
s-1,25(OH)2D in elderly. Several other studies have
reported the same inverse association in African-Ameri-
cans [9,10] and in Asian Indians [1]. However, a usual
finding when studying vitamin D deficient subjects of the
elderly Caucasian population is a positive relationship
between s-25(OH)D and 1,25(OH)2D, implying that
when s-25(OH)D is low, production of the active hor-
mone may be restricted by lack of substrate [16]. This
seemed to be the situation also in our population of adult
Pakistanis and Norwegians. The association seemed to be
stronger in Pakistanis, who had a higher prevalence of
Age- and gender-adjusted estimated marginal means of s-Ca2+ t iff rent s-iPTH in Pakistanis (n = 161) (—) and Nor-wegians (n = 560) (- - -)Figure 1
Age- and gender-adjusted estimated marginal means 
of s-Ca2+ at different s-iPTH in Pakistanis (n = 161) 
(—) and Norwegians (n = 560) (- - -). Note that there 
are few observations (n = 46) at serum parathyroid hormone 
levels above 9 pmol/l.Page 4 of 6
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in vitamin D stores may increase compensatory produc-
tion of 1,25(OH)2D at higher concentrations of
s-25(OH)D, but that this does not happen when levels are
very low such as in our sample of Pakistanis.
It is not clear whether possible alterations in the vitamin
D endocrine system may be due to genetic/biologic or life-
style factors, or a combination of these. Obesity may be a
contributing factor, as an inverse association between s-
25(OH)D and BMI [17-20] or percentage body fat [21]
has been reported. A US study on 302 healthy subjects
found lower s-1,25(OH)2D in obese compared with non-
obese men and women, although the obese subjects had
lower s-25(OH)D and higher s-iPTH [22]. The Pakistanis
living in Oslo have a high prevalence of obesity as well as
a high waist hip ratio for their BMI compared with other
ethnic groups [23]. Thus, ethnic differences in the vitamin
D endocrine system could, at least partly, be attributable
to differences in body size. When studying subjects of
Asian background living in Oslo, we observed an
increased prevalence of vitamin D deficiency in over-
weight compared with normal-weight women of Paki-
stani and other Asian background, but not in men [24].
We are not aware of any published data which have
shown that s-1,25(OH)2D is inversely associated with
BMI in subjects from the Indian subcontinent. In this
study, we observed an inverse association between BMI
and s-1,25(OH)2D in Norwegians but not in Pakistanis.
This was, however, apparent only when comparing obese
subjects (BMI > = 30) to non-obese (not shown). Differ-
ences in BMI or waist hip ratio could not explain the eth-
nic differences we found in s-1,25(OH)2D.
The Pakistanis had low s-25(OH)D, relatively lower
s-1,25(OH)2D, and high s-iPTH, but they had normal
s-Ca2+ when expressed as adjusted to pH 7.40. Although
s-Ca2+ is strictly hormonally regulated within a narrow
range, the levels were statistically significantly higher in
the Pakistanis than in the Norwegians. The results may
reflect true higher s-Ca2+ in Pakistanis, or a different pH in
Norwegians and Pakistanis. If true s-Ca2+ were similar, our
results may arise from a higher pH in the Pakistanis, lead-
ing to overestimation of s-Ca2+ values when adjusting the
results to a lower pH of 7.40. A more alkaline environ-
ment would imply a protection against bone resorption in
the Pakistanis. Vaitkevicius et al. found similar plasma pH
in African-Americans and Caucasian Americans but lower
urinary acid and calcium excretion in African-Americans,
and they suggested that alkali administration may be
equally important as calcium administration for bone
mineralization [25]. Several unidentified factors may con-
tribute to a differing pH and calcium metabolism between
ethnic groups. Systemic acidosis is produced by a variety
of factors such as menopause, heavy exercise, or dietary
acid load, and it is known to induce long-term activation
of osteoclasts, in order to release calcium and phosphate
into the circulation as a buffer [26]. However, this is not
in accordance with our findings on pH in venous serum
samples, which suggest a slightly lower pH in Pakistanis. If
the observed levels in the serum samples reflect true pH in
serum, this would imply that the true ethnic difference in
s-Ca2+ is even higher than that observed. A true ethnic dif-
ference in blood pH has not been established, and would
require more sophisticated methods such as measurement
of arterial blood gases.
S-Ca2+ was not associated with serum levels of vitamin D
metabolites in our study, but s-Ca2+ was strongly inversely
associated with s-iPTH in both ethnic groups, suggesting
that secondary hyperparathyroidism is induced by low
s-Ca2+, regardless of ethnic background. However, at any
s-iPTH level, Pakistanis had higher s-Ca2+. This may sug-
gest a higher set point of calcium in Pakistanis, involving
a higher PTH secretion as a response to s-Ca2+ [27]. The
differences may also be due to lifestyle factors – such as
the dietary acid load, or a combination of several factors.
The implications of a higher s-Ca2+ for bone metabolism
and bone health in Pakistani immigrants need to be fur-
ther studied.
Conclusion
Immigrants with Pakistani background living in Oslo,
who had low s-25(OH)D and high s-iPTH, also had sig-
nificantly lower s-1,25(OH)2D compared with ethnic
Norwegians. Although obesity was inversely related to
s-1,25(OH)2D in Norwegians, the lower s-1,25(OH)2D in
Pakistanis could not be explained by BMI. Interestingly,
s-Ca2+ was higher in Pakistanis than in ethnic Norwegians
for any s-iPTH in the normal range, also when controlling
for age. The explanation for this is unclear given current
knowledge of calcium metabolism.
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